Synthesis and Evaluation of Coumarin–Resveratrol Hybrids as 15-Lipoxygenaze Inhibitors

REFERENCES

• (a) Kennedy, R. O.; Thornes, R. D. Coumarins: Biology, Applications, and Mode of Action; John Wiley & Sons: New York, 1997; (b) Venugopala, K. N.; Rashmi, V.; Odhav, B. Review on natural coumarin lead compounds for their pharmacological activity. Biomed. Res. Int. 2013, 2013, 1–14.
   Google Scholar
• Sandhu, S.; Bansal, Y.; Silakari, O.; Bansal, G. Coumarin hybrids as novel therapeutic agents. Bioorg. Med. Chem. 2014, 22, 3806–3814.
   PubMed Web of Science ®Google Scholar
• (a) Cravotto, G.; Nano, G. M.; Palmisano, G.; Tagliapietra, S. An asymmetric approach to coumarin anticoagulants via hetero-Diels–Alder cycloaddition. Tetrahedron Asymmetry 2001, 12, 707–709; (b) Manolov, I.; Danchev, N. D. Synthesis, toxicological, and pharmacological assessment of some 4-hydroxycoumarin derivatives. Eur. J. Med. Chem. 1995, 30, 531–535; (c) Choure, R.; Pitre, K. S. Structural modification of coumarin for its increased anticoagulation potency. Can. J. Chem. Eng. Technol. 2010, 1, 7–15.
   Web of Science ®Google Scholar
• (a) Schio, L.; Chatreaux, F.; Klich, M. Tosylates in palladium-catalysed coupling reactions: Application to the synthesis of arylcoumarin inhibitors of gyrase B. Tetrahedron Lett. 2000, 41, 1543–1547; (b) Lad, H. B.; Giri, R. R.; Brahmbhatt, D. I. An efficient synthesis of some new 3-bipyridinyl substituted coumarins as potent antimicrobial agents. Chin. Chem. Lett. 2013, 24, 227–229.
   Web of Science ®Google Scholar
• Lacy, A.; O’Kennedy, R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr. Pharm. Des. 2004, 10, 3797–3811.
   PubMed Web of Science ®Google Scholar
• Witaicenis, A.; Seito, L. N.; Chagas, A. S.; Junior, L. D. A.; Luchini, A. C.; Rodrigues-Orsi, P.; Cestari, S. H.; Stasi, L. C. D. Antioxidant and intestinal anti-inflammatory effects of plant-derived coumarin derivatives. Phytomedicine 2014, 21, 240–246.
   PubMed Web of Science ®Google Scholar
• (a) Mao, P. C.-M.; Mouscadet, J. F.; Leh, H.; Christian, A.; Hsu, L. Y. Chemical modification of coumarin dimer and HIV-1 integrase inhibitory activity. Chem. Pharm. Bull. 2002, 50, 1634–1637; (b) Yu, D.; Suzuki, M.; Xie, L.; Morris-Natschke, S. L.; Lee, K. H. Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Med. Res. Rev. 2003, 23, 322–345; (c) Olomola, T. O.; Klein, R.; Mautsa, N.; Sayed, Y.; Kaye, P. T. Synthesis and evaluation of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors. Bioorg. Med. Chem. 2013, 21, 1964–1971.
   PubMed Web of Science ®Google Scholar
• (a) Anand, P.; Singh, B.; Singh, N. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer’s disease. Bioorg. Med. Chem. 2012, 20, 1175–1180 (b) Karatas, M. O.; Alici, B.; Cakir, U.; Cetinkaya, E.; Demir, D.; Ergün, A.; Gençer, N.; Arslan, O. Synthesis and carbonic anhydrase inhibitory properties of novel coumarin derivatives. J. Enzyme Inhib. Med. Chem. 2013, 28, 299–304.
   PubMed Web of Science ®Google Scholar
• Nikhil, B.; Shikha, B.; Anil, P.; Prakash, N. B. Diverse pharmacological activities of 3-substituted coumarins: A review. Int. Res. J. Pharm. 2012, 3, 24–29.
   Google Scholar
• Zhao, H.; Yan, B.; Peterson, L. B.; Blagg, B. S. J. 3-Arylcoumarin derivatives manifest anti-proliferative activity through Hsp90 inhibition. ACS Med. Chem. Lett. 2012, 3, 327–331.
   PubMed Web of Science ®Google Scholar
• (a) Svinyarov, I.; Bogdanov, M. G. One-pot synthesis and radical scavenging activity of novel polyhydroxylated 3-arylcoumarins. Eur. J. Med. Chem. 2014, 78, 198–206; (b) Matosa, M. J.; Pérez-Cruzc, F.; Vazquez-Rodrigueza, S.; Uriartea, F.; Santanaa, L.; Borgesb, F.; Olea-Azarc, C. Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins. Bioorg. Med. Chem. 2013, 21, 3900–3906.
   PubMed Web of Science ®Google Scholar
• Mattsson, C.; Svensson, P.; Sonesson, C. A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors. Eur. J. Med. Chem. 2014, 73, 177–186.
   PubMed Web of Science ®Google Scholar
• (a) Trkovnik, M.; Ivezic, Z. Syntheses of some new coumarin-quinolone carboxylic acids. J. Heterocycl. Chem. 2000, 37, 137–141; (b) Mashraqui, S. H.; Vashi, D.; Mistry, H. D. Efficient synthesis of 3-substituted coumarins. Synth. Commun. 2004, 34, 3129–3134 (c) Matos, M. J.; Viña, D.; Picciau, C.; Orallo, F.; Santana, L.; Uriarte, E. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg. Med. Chem. Lett. 2009, 19, 3268–3270.
   Web of Science ®Google Scholar
• (a) Potdar, M. M.; Mohile, S. S.; Salunkhe, M. M. Coumarin syntheses via Pechmann condensation in Lewis acidic chloroaluminate ionic liquid. Tetrahedron Lett. 2001, 42, 9285–9287; (b) Ming, Y.; Boykin, D. W. A convenient synthesis of 3-aryl coumarins. Heterocycles 1987, 26, 3229–3231; (c) Santana, L.; González-Díaz, H.; Quezada, E.; Uriarte, E.; Yáñez, M.; Viña, D.; Orallo, F. Quantitative structure–activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J. Med. Chem. 2008, 51, 6740–6751.
   Web of Science ®Google Scholar
• (a) Mali, R. S.; Tilve, S. G. Useful synthesis of coumestans. Synth. Commun. 1990, 20, 1781–1791; (b) Bogdal, D. Coumarins: Fast synthesis by the Knoevenagel condensation under microwave irradiation. J. Chem. Res. 1998, 468–469.
   Web of Science ®Google Scholar
• Mali, R. S.; Joshi, P. P. Useful syntheses of prenylated- and pyrano-3-arylcoumarins. Synth. Commun. 2001, 31, 2753–2767.
   Web of Science ®Google Scholar
• (a) Prasad, A. K.; Pati, H. N.; Azim, A.; Trikha, S.; Poonam. Lipase-catalysed regio- and enantioselective deacetylation of 2,4-diacetoxyphenyl alkyl ketones. Bioorg. Med. Chem. 1999, 7, 1973–1977; (b) Madkour, H. M. F. Synthesis and reactions of some 3-cyano-4-methylcoumarins. Heterocycles 1993, 36, 947–959.
   PubMed Web of Science ®Google Scholar
• Roussaki, M.; Kontogiorgis, C. A.; Hadjipavlou-Litina, D.; Hamilakis, S.; Detsi, A. A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity. Bioorg. Med. Chem. Lett. 2010, 20, 3889–3892.
   PubMed Web of Science ®Google Scholar
• Sashidhara, K. V.; Palnati, G. R.; Avula, S. R.; Kumar, A. Efficient and general synthesis of 3-aryl coumarins using cyanuric chloride. Synlett 2012, 4, 611–621.
   Web of Science ®Google Scholar
• Sabitha, M. G.; Subba Rao, A. V. Synthesis of 3-arylcoumarins, 2-aroylbenzofurans, and 3-aryl-2H-1,4-benzoazines under phase-transfer catalysis conditions. Synth. Commun. 1987, 17, 341–354.
   Web of Science ®Google Scholar
• (a) Saeedi, M.; Mahdavi, M.; Foroumadi, A.; Shafiee, A. Synthesis of novel fused 4,5-dihydro-1,2,3-triazolo[1,5-a][1,4]benzodiazepine derivatives via four-component Ugi–Smiles-type reaction. Tetrahedron 2013, 69, 3506–3510; (b) Asadi, M.; Ebrahimi, M.; Mahdavi, M.; Saeedi, M.; Ranjbar, P. R.; Yazadani, F.; Shafiee, A.; Foroumadi, A. Reaction of isatoic anhydride, amine, and N,N′-dialkyl carbodiimides under solvent-free conditions: New and efficient synthesis of 3-alkyl-2-(alkylamino)quinazolin-4(3H)-ones. Synth. Commun. 2013, 43, 2385–2392; (c) Mahdavi, M.; Shirazi, M. S.; Taherkhani, R.; Saeedi, M.; Alipour, E.; Moghadam, F. H.; Moradi, A.; Nadri, H.; Emami, S.; Firoozpour, L.; Shafiee, A.; Foroumadi, A. Synthesis, biological evaluation, and docking study of 3-aroyl-1-(4-sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors. Eur. J. Med. Chem. 2014, 82, 308–313; (d) Asadipour, A.; Alipour, M.; Jafari, M.; Khoobi, M.; Emami, S.; Nadri, H.; Sakhteman, A.; Moradi, A.; Sheibani, V.; Moghadam, F. H.; Shafiee, A.; Foroumadi, A. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors. Eur. J. Med. Chem. 2013, 70, 623–630; (e) Ketabforoosh S. H.; Kheirollahi, A.; Safavi, M.; Esmati, N.; Ardestani, S. K.; Emami, S.; Firoozpour, L.; Shafiee, A.; Foroumadi, A. Synthesis and anti-cancer activity evaluation of new dimethoxylated chalcone and flavanone analogs. Arch. Pharm. 2014. doi:10.1002/ardp.201400215; (f) Alipour, M.; Khoobi, M.; Moradi, A.; Nadri, H.; Moghadam, F. H.; Emami, S.; Hasanpour, Z.; Foroumadi, A.; Shafiee, A. Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives. Eur. J. Med. Chem. 2014, 82, 536–544; (g) Alipour, E.; Mousavi, Z.; Safaei, Z.; Pordeli, M.; Safavi, M.; Firoozpour, L.; Mohammadhosseini, N.; Saeedi, M.; Ardestani, S. K.; Shafiee, A.; Foroumadi, A. Synthesis and cytotoxic evaluation of some new[1,3]dioxolo[4,5-g]chromen-8-one derivatives. Daru J. Pharm. Sci. 2014, 22, 41; (h) Alipour, M.; Khoobi, M.; Emami, S.; Fallah-Benakohal, S.; Ghasemi-Niri, S. F.; Abdollahi, M.; Foroumadi, A.; Shafiee, A. Antinociceptive properties of new coumarin derivatives bearing substituted 3,4-dihydro-2H-benzothiazines. Daru J. Pharm. Sci. 2014, 22, 9.
   Web of Science ®Google Scholar
• Gadakh, B. K.; Patil, P. R.; Malik, S.; Kartha, K. P. R. Novel selectivity in carbohydrate reactions, IV: DABCO-mediated regioselective primary hydroxyl protection of carbohydrates. Synth. Commun. 2009, 39, 2430–2438.
   Web of Science ®Google Scholar
• Li, J. H.; Wang, D. P.; Xie, Y. X. CuI/DABCO as a highly active catalytic system for the Heck-type reaction. Tetrahedron Lett. 2005, 46, 4941–4944.
   Web of Science ®Google Scholar
• Munch, H.; Hansen, J. S.; Pittelkow, M.; Christensen, J. B.; Boas, U. A new efficient synthesis of isothiocyanates from amines using di-tert-butyl dicarbonate. Tetrahedron Lett. 2008, 49, 3117–3119.
   Web of Science ®Google Scholar
• Cecchi, L.; De Sarlo, F.; Machetti, F. Isoxazoline derivatives from activated primary nitro compounds and tertiary diamines. Tetrahedron Lett. 2005, 46, 7877–7879.
   Web of Science ®Google Scholar
• (a) Jiang, N.; Ragauskas, A. J. Vanadium-catalyzed selective aerobic alcohol oxidation in ionic liquid [bmim]PF6. Tetrahedron Lett. 2007, 48, 273–276; (b) Heravi, M. M.; Derikvand, F.; Ghassemzadeh, M.; Neumuller, N. Synthesis, characterization, and structure of a tetrameric DABCO–bromine complex: A novel oxidizing agent for oxidation of alcohols to carbonyl compounds. Tetrahedron Lett. 2005, 46, 6243–6245.
   Web of Science ®Google Scholar
• Yan, M. C.; Jang, Y. J.; Yao, C. F. An easy and efficient method for the synthesis of 2,2-dialkyl-3-nitrochromene. Tetrahedron Lett. 2001, 42, 2717–2721.
   Web of Science ®Google Scholar
• Malterud, K. E.; Rydland, K. M. Inhibitors of 15-lipoxygenase from orange peel. J. Agric. Food Chem. 2000, 48, 5576–5580.
   PubMed Web of Science ®Google Scholar
• Fadeyi, O. O.; Daniels, R. N.; DeGuire, S. M.; Lindsley, C. Total synthesis of polemannones B and C. Tetrahedron Lett. 2009, 50, 3084–3087.
   Web of Science ®Google Scholar